Given the increasing prevalence of diabetes and obesity worldwide, the deleterious effects
of non-alcoholic fatty liver disease (NAFLD) are becoming a growing challenge for public …

Nonalcoholic fatty liver disease (NAFLD) and its inflammatory and often progressive subtype
nonalcoholic steatohepatitis (NASH) are becoming the leading cause of liver-related …

Hepatic lipid droplets (LDs) and peroxynitrite (ONOO–) levels are closely related to
nonalcoholic fatty liver disease (NAFLD). Additionally, some drug-induced liver injury (DILI) …

Obesity is now a worldwide epidemic ensuing an increase in comorbidities' prevalence,
such as insulin resistance, type 2 diabetes (T2D), metabolic dysfunction-associated fatty …

Obesity is characterized by the deposition of excessive body fat, and is caused by energy
imbalance, especially when consuming fat-rich diets. High fat diet (HFD)-associated obesity …

Simple Summary A large number of studies report that medicinal herbs and many food
ingredients protect against the development of liver disease because they possess …

Nonalcoholic fatty liver disease (NAFLD) constitutes a major health concern with the
increasing incidence of obesity and diabetes in many Western countries, reaching a …

Non-alcoholic fatty liver disease (NAFLD) can manifest as non-alcoholic fatty liver (NAFL) or
non-alcoholic steatohepatitis (NASH). NASH is often associated with progressive fibrosis …

Non-alcoholic fatty liver disease (NAFLD) is the most common form of liver disease all over
the world due to the obesity pandemic; currently, therapeutic options for NAFLD are scarce …

Background & Aims We studied the role of interleukin 11 (IL11) signaling in the
pathogenesis of nonalcoholic steatohepatitis (NASH) using hepatic stellate cells (HSCs) …